Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 9/20 | 0.56 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9933436 | 0.95 | CA2 (0.58) | CA2CA1CYP3A4TSHRATM | |
| SCHEMBL9933922 | 0.95 | CA2 (0.58) | CA2CA1CYP3A4TSHRATM | |
| SCHEMBL3807521 | 0.95 | CA2 (0.58) | CA2CA1CYP3A4TSHRATM | |
| SCHEMBL2904337 | 0.95 | CA2 (0.58) | CA2CA1CYP3A4TSHRATM | |
| SCHEMBL20767415 | 0.95 | CA2 (0.58) | CA2CA1CYP3A4TSHRATM | |
| SCHEMBL3326003 | 0.95 | CA2 (0.58) | CA2CA1CYP3A4TSHRATM | |
| SCHEMBL7223059 | 0.90 | CYP3A4 (0.58) | CA2CA1CYP3A4TSHRATM | |
| SCHEMBL28900906 | 0.90 | CYP3A4 (0.58) | CA2CA1CYP3A4TSHRATM | |
| SCHEMBL3795613 | 0.90 | TSHR (0.45) | CA2CA1CYP3A4TSHRATM | |
| SCHEMBL3800674 | 0.88 | CA2 (0.49) | CA2CA1CYP3A4TSHRATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2550954-B1 | VASELINE-LIKE COMPOSITION, AND COSMETIC PREPARATION | NISSHIN OILLIO GROUP LTD (JP) | 2020-03-04 | — | — | EP | disclosed |
| EP-2494952-B1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | NISSHIN OILLIO GROUP LTD (JP) | 2018-02-28 | — | — | EP | disclosed |
| US-9028848-B2 | Composition for cosmetics, cosmetic, method for producing oil-in-water emulsion cosmetic, and two separate layer-type cosmetic | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2015-05-12 | — | — | US | disclosed |
| US-9028850-B2 | Composition for cosmetics, cosmetic, method for producing oil-in-water emulsion cosmetic, and two separate layer-type cosmetic | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2015-05-12 | — | — | US | disclosed |
| US-20130303634-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | NISSHIN OILLIO GROUP LTD (JP) | 2013-11-14 | — | — | US | disclosed |
| EP-2550954-A1 | VASELINE-LIKE COMPOSITION, AND COSMETIC PREPARATION | The Nisshin Oillio Group, Ltd. (JP) | 2013-01-30 | — | — | EP | disclosed |
| US-20130005808-A1 | VASELINE-LIKE COMPOSITION AND COSMETIC | The Nisshin OilliO Group ,Ltd. (JP) | 2013-01-03 | — | — | US | disclosed |
| EP-2494952-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | The Nisshin Oillio Group, Ltd. (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-20120156271-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| CN-101141944-B | Cosmetic compositions containing esters based on 2-propylheptanol | COGNIS IP MAN GMBH | 2012-05-23 | — | — | CN | disclosed |
| CN-101141944-A | Cosmetic compositions containing esters based on 2-propylheptanol | COGNIS IP MAN GMBH (DE) | 2008-03-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120156271-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | GK, DGKG, MGLL | CA2 3614/4885CA1 4716/4885CYP3A4 4481/4885 |
| US-20130303634-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | GK, DGKA, DGKG | CA2 2541/4885CA1 4610/4885CYP3A4 4320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.